~~ Divis Laboratories Limited

Date 5th February 2016

The Secretary BSE Limited 1st Floor New Trading Ring Rotunda Bldg PJ Towers Dalal Street Fort MUMBAI - 400 023

Dear Ir

Sub Un-audited financial results for the quarter and nine months ended 31st December 2015 and limited review report -reg

Ref Stock code 532488

Pursuant to Regulation 33 of B[ (Listing Obligations and Disclosure

Requirements) Regulation 2015 please find enclosed un-audited financial results

along with the limited review report [or the quarter and nine months ended 31 5t

Dec mber 2015

Above un-audited financials were approved and taken on record by the Board of

Directors o[the Company at their meeting held on Friday 5th February 20 16

The Company proposes release of press note as per the enclosed format This is

for your information and r cords Kindly acknowledge the receipt of the same

Thanking You

Yours faithfully For Divis Laboratories Limited

i2 IoJ L-shy

P V ~Cgta~shmi Rajani Company Secretary (ACS 18882)

CIN L2411 OTG1990PLC011854

An ISO-9001 150-14001 and OHSAS-18001 Triple certified company Regd Off Divi Towers 7-1-771Fl1303 Dharam Karan Road Ameerpet Hyderabad - 500 016 INDIA

Tel 91-40-23786300 Fax 91-40-2378 6460 E-mail maildivislabomtoriescom Website wwwdivislabomtoriescom

DIVIS LABORATORIES LIMITED

UN-AUDIl ED FINA CIAL RESULTS (Sr ANDA LONE) FOR TILE QUARTER A D NINE ONTIIS ENDED 31 DECEMBER 20 15

(Rsin Lakbs)

Particulars STANDALONE Quarter ended Nine Monlhs ended Year

Ended 31122015 30092015 311220 14 31122015 31122014 31032015

Unaudited Unaudited Unaud ited Unaudited Unaudited Audited

(I ) (2) (3 ) (4) (5) (6) (7)

I Income from operations (a) Net SalesIncome from

o[lerations (Net of Excise Dul))

85177 96187 78808 262055 225 761 307230

(b) Other Operat ing Income 110 245 304 540 93J 1171 Total rncome from operations (net)

85287 96432 79 112 262595 226692 308401

2 Expenses

a Cost of materials consumed 33258 42106 34672 110931 105441 144627 h Purchases of stock-in-trade 0 0 0 c Changes in in vent ries of

l1 nished good work-i nshyprogress and slock-in-trade

(1512) (3571 ) (2808) (8596) ( 13626) (23083)

d Emplo ee benetits expense 9118 8595 7459 25746 20425 283 15 c Depreciation and amortization

expense 2988 3007 2879 8887 9131 13585

r Other Expenses 12194 11702 11080 34700 31546 42337 Total Expenses 56046 61839 53282 ]71668 152917 205781

3 Profit from Operations before Olher Income Finance Costs amp Exceptional Items (1-2)

29241 34593 25830 90927 73775

-

102620

4 Other Income 1520 2964 1994 7883 481 7 4284 5 Pro lit from ordinary activities

before flnnnce costs amp exceptional Uems (3+4)

30761 37557 27824 98810 78592 106904

6 r inante Costs 23 34 48 79 1 27 186 7 Prolit from ordinary activities

after linance costs but before exceptionnlltems (5-6)

30738 37523 27776 98731 78465 106718

8 Exc[llional items 0 0 0 0 0 0 Profit from ordinary activities

before Tax (7-8) 30738 37523 27776 98731 78465 106718

10 rax Expense 6082 7950 5718 20184 16650 22012 I I Net Profit from ordinary activitie

after Tax (9- 10) 24656 29573 22058 78547 61815 84706

12 Elra-ordinary itcms (net of tax expcnse)

0 0 0 0 0 0

13 Net Profit (+)Loss(-) for the period (11-12)

24656 29573 22058 78547 61815 84706

14 Paid-up Equity Share Capital (face Value Rs2 per share) 5309 5309 2655 5309 2655 2655

15 Reserves excluding revaluation rese rves as per balance sheet of previous accounting year 35354 1

16 Earnings per Share (of Rs21- each) (not annualized) a) Basic b) Diluted

929 929

11 14 11 14

83 1 83 1

2959 2959

2329 2329

3191 3 19 1

NOTES I The above results for the quarter ended 31 1 Dece mber 2015 as reviewed by the Audit Comm ittee were considered and

approved by the Board of Directors at its meeting held on Sd1 February 2016 and were subjected to limited review by the Auditors

2 The Company is primarily engaged in the manufacture of Active Pharmaceutical Ingredients and intennediates Accordingly there are no reportable segments as p r Accounting Standard 17 notified under the Compan ies Act 1956

3 The company has opted to publish quarter ly unaud ited standalone resul ts and to publish consol idated results at the year end

4 D 1 f ft I b I R L kh etal so orex gam oss are gIven eow sm a s

Particulars Quarter ended Nine Months ended Year Ended

31122015 30092015 311220 14 31122015 3 1 1220 14 31 03201 5

Unaudited Unaudi ted Unaudited Unaudited Unaudi ted Audited

Forx Oain(Loss) 294 1166 1116 3582 1683 ( lOS) Forex gam has been mcluded m Other Income and forex loss has been IIlcluded 111 Other Expenses

5 Bonus Issue The company has allolled 132734290 bonus shares of Rs2 each to the members on 281h September 2015 Earnings per Share has been adjusted for previous periods presented due to the bonus issue in accordance with Accounting Standard No20

6 Upon enactment of the Payment of Bonus (Amendment) Act 2015 the company has made add itional provision for bonus to employees during the quart r amounting to RS25 7 lakhs for the previous year 20 14- 15

7 Figures for the previous yearperiod have been regrouped or reclassified wherever necessary

Place Visakhapatnam Date 05-02-2016

Chairman amp Manag ing Director

PVR K Nageswara Rao amp Co Chartered Accountants

INDEPENDENT AUDITORS REVIEW REPORT

TO THE BOARD OF DIRECTORS OF DIVIS LADORA TORIE LlMlTED

We haw reviewed the accompanying statement of Standalone Unaudited Financia l Result f D1vrs LABORATORlE LIMITED (the company) for the quarter Clnd snine months ended 31 December 2015 (the tatement) This statement is the respons ibility of the Companys Management and has been approved by the Board f Directors Qur responsibility is to issue a report on the Statement based on our rev iew

We conducted Ollr review of the Statement in accordance with the Standard on Review Lngugemenls (SRE) 241 0 Review of Interim Financial Informat ion Performed by the Independen t Auditor of the Entity issued by the Institu te of Chartered A(c OLll1lanL of Ind ia Thi standard requires that we plan and perform the rev iew LO obtain moderat a slirance as to whether the Statement is free of material misstatement A rev iew is limited primarily to inquiries of Company personnel and analytical procedures applied to

ti lluncial data and thu provide less assurance than an alldit We have not performed an audit andaccordingly we do not express an audit opin ion

Based on our review contll ted as Slated above nothing has come to ollr allen tion that callses liS to believe that the accompanying Statement prepared in accordance with th~ applicable Accounting Standards and other recognised accounting practices anu polic ies has not di closed the information required to be di closed in terms of Regul atio n 1 of lhl SEB I (Listing Obligation and Disclosure Requirements) Regulations 2015 inc lud ing thl manner in which it is to be disclosed or that it contains any materia l misstatement

For PVRK NAGE WARA RAO amp Co

Partner VlSAKHAPATNAM 05022016

Membersh ip Number23939

109 Metro Residency I 6-3middot1247 RaJbhavan Road I Khairatabad Hyderabad - 500082 I India () Off +91-40-23311609 +91-40-23312269 (Oir) I Fax +91-40middot2331 9591 I E-mail pvrkpvrkcom

15 Reserves excluding revaluation rese rves as per balance sheet of previous accounting year 35354 1

16 Earnings per Share (of Rs21- each) (not annualized) a) Basic b) Diluted

929 929

11 14 11 14

83 1 83 1

2959 2959

2329 2329

3191 3 19 1

NOTES I The above results for the quarter ended 31 1 Dece mber 2015 as reviewed by the Audit Comm ittee were considered and

approved by the Board of Directors at its meeting held on Sd1 February 2016 and were subjected to limited review by the Auditors

2 The Company is primarily engaged in the manufacture of Active Pharmaceutical Ingredients and intennediates Accordingly there are no reportable segments as p r Accounting Standard 17 notified under the Compan ies Act 1956

3 The company has opted to publish quarter ly unaud ited standalone resul ts and to publish consol idated results at the year end

4 D 1 f ft I b I R L kh etal so orex gam oss are gIven eow sm a s

Particulars Quarter ended Nine Months ended Year Ended

31122015 30092015 311220 14 31122015 3 1 1220 14 31 03201 5

Unaudited Unaudi ted Unaudited Unaudited Unaudi ted Audited

Forx Oain(Loss) 294 1166 1116 3582 1683 ( lOS) Forex gam has been mcluded m Other Income and forex loss has been IIlcluded 111 Other Expenses

5 Bonus Issue The company has allolled 132734290 bonus shares of Rs2 each to the members on 281h September 2015 Earnings per Share has been adjusted for previous periods presented due to the bonus issue in accordance with Accounting Standard No20

6 Upon enactment of the Payment of Bonus (Amendment) Act 2015 the company has made add itional provision for bonus to employees during the quart r amounting to RS25 7 lakhs for the previous year 20 14- 15

7 Figures for the previous yearperiod have been regrouped or reclassified wherever necessary

Place Visakhapatnam Date 05-02-2016

Chairman amp Manag ing Director

PVR K Nageswara Rao amp Co Chartered Accountants

INDEPENDENT AUDITORS REVIEW REPORT

TO THE BOARD OF DIRECTORS OF DIVIS LADORA TORIE LlMlTED

We haw reviewed the accompanying statement of Standalone Unaudited Financia l Result f D1vrs LABORATORlE LIMITED (the company) for the quarter Clnd snine months ended 31 December 2015 (the tatement) This statement is the respons ibility of the Companys Management and has been approved by the Board f Directors Qur responsibility is to issue a report on the Statement based on our rev iew

We conducted Ollr review of the Statement in accordance with the Standard on Review Lngugemenls (SRE) 241 0 Review of Interim Financial Informat ion Performed by the Independen t Auditor of the Entity issued by the Institu te of Chartered A(c OLll1lanL of Ind ia Thi standard requires that we plan and perform the rev iew LO obtain moderat a slirance as to whether the Statement is free of material misstatement A rev iew is limited primarily to inquiries of Company personnel and analytical procedures applied to

ti lluncial data and thu provide less assurance than an alldit We have not performed an audit andaccordingly we do not express an audit opin ion

Based on our review contll ted as Slated above nothing has come to ollr allen tion that callses liS to believe that the accompanying Statement prepared in accordance with th~ applicable Accounting Standards and other recognised accounting practices anu polic ies has not di closed the information required to be di closed in terms of Regul atio n 1 of lhl SEB I (Listing Obligation and Disclosure Requirements) Regulations 2015 inc lud ing thl manner in which it is to be disclosed or that it contains any materia l misstatement

For PVRK NAGE WARA RAO amp Co

Partner VlSAKHAPATNAM 05022016

Membersh ip Number23939

109 Metro Residency I 6-3middot1247 RaJbhavan Road I Khairatabad Hyderabad - 500082 I India () Off +91-40-23311609 +91-40-23312269 (Oir) I Fax +91-40middot2331 9591 I E-mail pvrkpvrkcom

PVR K Nageswara Rao amp Co Chartered Accountants

INDEPENDENT AUDITORS REVIEW REPORT

TO THE BOARD OF DIRECTORS OF DIVIS LADORA TORIE LlMlTED

We haw reviewed the accompanying statement of Standalone Unaudited Financia l Result f D1vrs LABORATORlE LIMITED (the company) for the quarter Clnd snine months ended 31 December 2015 (the tatement) This statement is the respons ibility of the Companys Management and has been approved by the Board f Directors Qur responsibility is to issue a report on the Statement based on our rev iew

We conducted Ollr review of the Statement in accordance with the Standard on Review Lngugemenls (SRE) 241 0 Review of Interim Financial Informat ion Performed by the Independen t Auditor of the Entity issued by the Institu te of Chartered A(c OLll1lanL of Ind ia Thi standard requires that we plan and perform the rev iew LO obtain moderat a slirance as to whether the Statement is free of material misstatement A rev iew is limited primarily to inquiries of Company personnel and analytical procedures applied to

ti lluncial data and thu provide less assurance than an alldit We have not performed an audit andaccordingly we do not express an audit opin ion

Based on our review contll ted as Slated above nothing has come to ollr allen tion that callses liS to believe that the accompanying Statement prepared in accordance with th~ applicable Accounting Standards and other recognised accounting practices anu polic ies has not di closed the information required to be di closed in terms of Regul atio n 1 of lhl SEB I (Listing Obligation and Disclosure Requirements) Regulations 2015 inc lud ing thl manner in which it is to be disclosed or that it contains any materia l misstatement

For PVRK NAGE WARA RAO amp Co

Partner VlSAKHAPATNAM 05022016

Membersh ip Number23939

109 Metro Residency I 6-3middot1247 RaJbhavan Road I Khairatabad Hyderabad - 500082 I India () Off +91-40-23311609 +91-40-23312269 (Oir) I Fax +91-40middot2331 9591 I E-mail pvrkpvrkcom

DIVIS LABORATORIES LIMITED Hyderabad

PRESS RELEASE dated 5th February 2016

Divis Labs earns a PAT of Rs247 crores in Q3FY16

Divis Laboratories has earned a Profit after Tax (PAT) of Rs247 crores on

a total income of RS853 crores on a stand-a lone basis for the quarter

ended 31st December 2015 For the corresponding quarter of the last

year the company earned a PAT of RS221 crores on a total income of Rs

79 crores

Forex gain for the current quarter amounted to Rs3 crores as against a

forex gain of RSll crores during the corresponding quarter last year

The company has capitalized fixed assets aggregating to RS34 crores

during the current quarter

For the 9-month period ended 3pt December 2015 the company earned

a total income of RS2626 crores as compared to Rs 2267 crores during

the corresponding 9-month period of last year PBT for the current 9shy

month period came to RS987 crores as against a PBT of Rs 785 crores

for the previous period PAT for the current 9-months is Rs785 crores as

against Rs 618 crores for the previous period